Table 2.
Baseline characteristics and clinical characteristics of the study population.
| Measures | Overall (n = 791). Mean or n (SD or %) |
|---|---|
| Age (years) | 52.3 (12.0) |
| Gender, Female (n, %) | 488 (61.7) |
| Hypertension (n, %) | 262 (33.1) |
| Diabetes (n, %) | 58 (7.3) |
| Antihypertensive agents (n, %) | 193 (24.4) |
| Hypoglycemic agents (n, %) | 50 (6.3) |
| Lipid-lowering agents (n, %) | 155 (19.6) |
| SBP (mmHg) | 123.9 (16.1) |
| DBP (mmHg) | 76.2 (9.8) |
| Heart rate (bpm) | 70.9 (11.5) |
| Glycated hemoglobin (%) | 5.5 (0.6) |
| Serum glucose (mg/dL) | 90.2 (17.5) |
| Total cholesterol (mg/dL) | 204.0 (36.0) |
| HDL-cholesterol (mg/dL) | 58.7 (15.1) |
| LDL-cholesterol (mg/dL) | 124.5 (31.6) |
| Tryglicerides (mg/dL) | 110.4 (65.8) |
| Fibrinogen (mg/dL) | 358.9 (85.1) |
| BMI (kg/m2) | 27.8 (4.9) |
| Waist circumference (cm) | 95.1 (13.1) |
| Hip circumference (cm) | 105.0 (9.4) |
| Waist-height ratio | 0.58 (0.78) |
| Waist-hip ratio | 0.91 (0.10) |
| Adiposity index | 27.6 (6.4) |
| CVR | 10.1 (10.4) |
| Moderate and or vigorous physical activity (min/day) | 65.0 (30.9) |
Categorical variables are expressed as n (%) and continuous variables as mean ± standard deviation (SD). SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HDL: High-density lipoprotein cholesterol; LDL: Low-density lipoprotein cholesterol; BMI: Body mass index; CVR: Cardiovascular risk; cfPWV: Carotid femoral pulse wave velocity.